ID Source | ID |
---|---|
PubMed CID | 439977 |
SCHEMBL ID | 6816068 |
MeSH ID | M0103989 |
Synonym |
---|
ac2-lys-ala-ala |
(2s)-2-[[(2s)-2-[[(2s)-2,6-diacetamidohexanoyl]amino]propanoyl]amino]propanoic acid |
n(alpha), n-(epsilon)-diacetyl-lysyl-alanyl-alanine |
n(alpha),n(epsilon)-diacetyl-lys-ala-ala |
ac2-l-lys-d-ala-d-ala |
n-(alpha), n-(epsilon)-diacetyl-lysyl-alanyl-alanine |
n-(alpha), n-(epsilon)-diacetyl-lys-ala-ala |
d-alanine, n-(n-(n2,n6-diacetyl-l-lysyl)-d-alanyl)- |
n(alpha),n-(epsilon)-diacetyl-lysyl-alanyl-alanine |
SCHEMBL6816068 |
DTXSID80947444 |
n-[1-hydroxy-2-({1-hydroxy-2,6-bis[(1-hydroxyethylidene)amino]hexylidene}amino)propylidene]alanine |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.20) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |